Kanvas Biosciences

Our full-stack tech­nol­o­gy plat­form brings micro­bio­me drug dis­cov­ery into focus. Our spa­tial map­ping dis­cov­ery engine pro­vides stun­ning pic­tures of the inter­ac­tions and con­nec­tions between host and the micro­bio­me; an area of this vital sys­tem that we’ve nev­er been able to com­plete­ly under­stand before. Spa­tial biol­o­gy of the host-micro­bio­me inter­face pro­vides new oppor­tu­ni­ties for effec­tive ther­a­peu­tic inter­ven­tions, ulti­mate­ly enabling us to bet­ter treat patients.

Kanvas Biosciences headquartered in United States, North America, operates in the Biotechnology, Life Science sector. The company focuses on Biotechnology and has secured $682.0M in funding across 24 round(s). With a team of 11-50 employees, Kanvas Biosciences is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Kanvas Biosciences, raised $12.5M. Discover more about their projects, partnerships, and impact on our platform.